India's Supreme Court is expected to rule on a case with major implications for the global supply of generic medications. MSF's Leena Menghaney and Petros Isaakidis warn about the potential consequences for patients.

The Food and Drug Administration has granted accelerated approval for bedaquiline, the first tuberculosis drug to be developed in 40 years. Bedaquiline is "a potential game changer" in treating drug-resistant tuberculosis, according to Dr. Manica Balasegaram, executive director of MSF's Access Campaign.